Deals
Fresenius Is Leading Bidder for Pfizer’s Pumps Business
- Germany’s Fresenius said to be in advanced talks to buy assets
- U.K.’s Smiths Group said to no longer be in the running
This article is for subscribers only.
Fresenius SE, the largest publicly listed health-care provider in Europe, is the leading bidder to acquire Pfizer Inc.’s pumps and devices business, which could fetch $1.5 billion to $2 billion, according to people with knowledge of the matter.
Fresenius, based in Bad Homburg, Germany, is in advanced talks with Pfizer and an agreement could be reached as early as this month, said the people, asking not to be identified because the deliberations are private. Negotiations could still fall apart.